
Miltocef SL 1000mg/500mg Injection
Marketer
Pharmus Biotech
Salt Composition
Cefoperazone (1000mg) + Sulbactam (500mg)
Overview Miltocef SL 1000mg/500mg Injection
Ceftolozane/Tazobactam 1000mg/500mg injection is a dual-action antibiotic. It's used to combat a range of bacterial infections by inhibiting microbial growth and spread. Administration must be overseen by a medical professional. Complete the prescribed course, even with symptom improvement; premature cessation may reduce efficacy. Potential side effects include nausea, vomiting, diarrhea, and dyspepsia. Report worsening side effects to your physician promptly. Seek immediate medical attention for allergic reactions (e.g., rash, pruritus, edema, dyspnea). Inform your doctor about all current medications, including those for pre-existing conditions. Pregnant or lactating individuals should seek medical advice before use. Alcohol consumption should be avoided due to potential additive drowsiness. While usually non-impairing, avoid driving if drowsiness or dizziness occurs. Adequate rest, a balanced diet, and sufficient hydration will support recovery. Your doctor may order tests to monitor the drug's effects.
Primary Ingredients of Miltocef SL 1000mg/500mg Injection
The provided text is "undefined," therefore no rephrasing is possible.
Uses of Miltocef SL 1000mg/500mg Injection
Managing Bacterial Infections
Major Benefits of Miltocef SL 1000mg/500mg Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is strongly discouraged.
Common Side effects of Miltocef SL 1000mg/500mg Injection:
- Decreased white blood cell count (neutrophils)
- Decreased white blood cell count (lymphocytes)
- Decreased hemoglobin
- Decreased hematocrit level
- Low blood platelets
- Coagulation disorder
- Increased white blood cell count (eosinophils)
- Diarrhea
- Nausea
- Increased alanine aminotransferase
- Increased aspartate aminotransferase
- Increased alkaline phosphatase level in blood
- Vomiting
- Increased bilirubin in the blood
How to use Miltocef SL 1000mg/500mg Injection:
This medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
How Miltocef SL 1000mg/500mg Injection works:
Miltocef SL Injection (1000mg/500mg) combines Cefoperazone, a bacterial cell-wall synthesis inhibitor, with Sulbactam, a beta-lactamase inhibitor. This synergistic action disables bacterial defenses, boosting Cefoperazone's effectiveness and overcoming resistance mechanisms.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent use of Miltocef SL 1000mg/500mg Injection and alcohol can result in adverse effects including facial flushing, tachycardia, nausea, thirst, chest discomfort, and hypotension (a disulfiram-like reaction).
PregnancySAFE IF PRESCRIBED
The injectable formulation of Miltocef SL (1000mg/500mg) is typically regarded as safe for use in pregnancy. Preclinical trials in animals revealed minimal or no negative impacts on fetal development; nevertheless, clinical data from human studies are scarce.
Breast feedingSAFE IF PRESCRIBED
Ceftolozane/tazobactam 1000mg/500mg injection (Miltocef SL) is considered safe for breastfeeding mothers. Research in humans indicates minimal drug transfer to breast milk, posing no known risk to the infant.
DrivingCONSULT YOUR DOCTOR
The effect of Miltocef SL 1000mg/500mg Injection on driving ability is undetermined. Refrain from driving if you develop symptoms impairing concentration or reaction time.
KidneyCONSULT YOUR DOCTOR
Data regarding the administration of Miltocef SL 1000mg/500mg Injection to individuals with renal impairment is scarce. Physician consultation is advised.
LiverCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Miltocef SL 1000mg/500mg Injection to individuals with hepatic impairment. Seek medical advice.
What if you forget to take Miltocef SL 1000mg/500mg Injection :
Should you forget a scheduled dose of Miltocef SL 1000mg/500mg Injection, seek medical advice.
Facts to Know About Miltocef SL 1000mg/500mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
